[In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug].
Saved in:
| Title: | [In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug]. |
|---|---|
| Transliterated Title: | Actividad in vitro de delafloxacino frente a aislados clínicos de Pseudomonas aeruginosa resistentes a carbapenémicos en una etapa previa al uso clínico de este fármaco. |
| Authors: | García-Rivera C, Navarro M, Parra M, Sánchez Bautista A, Gómez I, Ventero MP; María-Paz Ventero, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Av. Pintor Baeza 12, 03010. Alicante, Spain. Maripazvm@gmail.com., Rodríguez JC |
| Source: | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2024 Feb; Vol. 37 (1), pp. 104-105. Date of Electronic Publication: 2023 Dec 22. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Sociedad Española de Quimioterapia Country of Publication: Spain NLM ID: 9108821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1988-9518 (Electronic) Linking ISSN: 02143429 NLM ISO Abbreviation: Rev Esp Quimioter Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38140799 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: [In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug]. – Name: TitleTranslated Label: Transliterated Title Group: TiAlt Data: Actividad in vitro de delafloxacino frente a aislados clínicos de Pseudomonas aeruginosa resistentes a carbapenémicos en una etapa previa al uso clínico de este fármaco. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22García-Rivera+C%22">García-Rivera C</searchLink><br /><searchLink fieldCode="AU" term="%22Navarro+M%22">Navarro M</searchLink><br /><searchLink fieldCode="AU" term="%22Parra+M%22">Parra M</searchLink><br /><searchLink fieldCode="AU" term="%22Sánchez+Bautista+A%22">Sánchez Bautista A</searchLink><br /><searchLink fieldCode="AU" term="%22Gómez+I%22">Gómez I</searchLink><br /><searchLink fieldCode="AU" term="%22Ventero+MP%22">Ventero MP</searchLink>; María-Paz Ventero, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Av. Pintor Baeza 12, 03010. Alicante, Spain. Maripazvm@gmail.com.<br /><searchLink fieldCode="AU" term="%22Rodríguez+JC%22">Rodríguez JC</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229108821%22">Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia</searchLink> [Rev Esp Quimioter] 2024 Feb; Vol. 37 (1), pp. 104-105. <i>Date of Electronic Publication: </i>2023 Dec 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sociedad+Española+de+Quimioterapia%22">Sociedad Española de Quimioterapia </searchLink><i>Country of Publication: </i>Spain <i>NLM ID: </i>9108821 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1988-9518 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202143429%22">02143429 </searchLink><i>NLM ISO Abbreviation: </i>Rev Esp Quimioter <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38140799 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.37201/req/080.2023 Languages: – Code: spa Text: Spanish; Castilian PhysicalDescription: Pagination: StartPage: 104 Titles: – TitleFull: [In vitro activity of delafloxacin against clinical isolates of carbapenem-resistant Pseudomonas aeruginosa in a stage prior to the clinical use of this drug]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: García-Rivera C – PersonEntity: Name: NameFull: Navarro M – PersonEntity: Name: NameFull: Parra M – PersonEntity: Name: NameFull: Sánchez Bautista A – PersonEntity: Name: NameFull: Gómez I – PersonEntity: Name: NameFull: Ventero MP – PersonEntity: Name: NameFull: Rodríguez JC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2024 Feb Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1988-9518 Numbering: – Type: volume Value: 37 – Type: issue Value: 1 Titles: – TitleFull: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia Type: main |
| ResultId | 1 |